Study finds an increase in safety related label changes for new drugs approved through the FDA’s expedited regulatory pathways

A new article that was recently published in the British Medical Journal found an increase in safety-related label changes in drugs approved through the FDA’s expedited pathway. Read more “Study finds an increase in safety related label changes for new drugs approved through the FDA’s expedited regulatory pathways”